Skip to main content
Log in

Tokolyse – Update 2016

Tocolysis – update 2016

  • Gynäkologie aktuell
  • Published:
Der Gynäkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. WHO (2012) Born too soon: the global action report on preterm birth. World Health Organization, Geneva (March of Dimes. PMNCH, S.t.C.)

    Google Scholar 

  2. Vogel JP et al (2014) Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health. Lancet 384(9957):1869–1877

    Article  CAS  PubMed  Google Scholar 

  3. Schoen CN et al (2015) Why the United States preterm birth rate is declining. Am J Obstet Gynecol 213(2):175–180

    Article  PubMed  Google Scholar 

  4. Zahn V (1984) Uterine contractions during pregnancy. J Perinat Med 12(3):107–113

    Article  CAS  PubMed  Google Scholar 

  5. Tsoi E et al (2003) Ultrasound assessment of cervical length in threatened preterm labor. Ultrasound Obstet Gynecol 21(6):552–555

    Article  CAS  PubMed  Google Scholar 

  6. Schleußner E (2013) Drohende Frühgeburt. Dtsch Arztebl Int 110(13):227–236

    PubMed  PubMed Central  Google Scholar 

  7. Hosli I et al (2014) Tocolysis for preterm labor: expert opinion. Arch Gynecol Obstet 289(4):903–909

    Article  CAS  PubMed  Google Scholar 

  8. ACOG (2012) Management of preterm labor. Obstet Gynecol 119(6):1308–1317

    Article  Google Scholar 

  9. Hiersch L et al (2014) The role of cervical length in women with threatened preterm labor: is it a valid predictor at any gestational age? Am J Obstet Gynecol 211(5):1–9

    Article  Google Scholar 

  10. Iams JD et al (2011) The rate of cervical change and the phenotype of spontaneous preterm birth. Am J Obstet Gynecol 205(2):130.e1–6

    Article  Google Scholar 

  11. Ting HS et al (2007) Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test. Ann Acad Med Singapore 36(6):399–402

    PubMed  Google Scholar 

  12. Nikolova T et al (2015) Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor. J Perinat Med 43(4):395–402

    CAS  PubMed  Google Scholar 

  13. van Baaren GJ et al (2014) Predictive value of cervical length measurement and fibronectin testing in threatened preterm labor. Obstet Gynecol 123(6):1185–1192

    Article  PubMed  Google Scholar 

  14. Vis JY et al (2015) Randomized comparison of nifedipine and placebo in fibronectin-negative women with symptoms of preterm labor and a short cervix (APOSTEL-I Trial). Am J Perinatol 32(5):451–460

    PubMed  Google Scholar 

  15. Romero R, Dey SK, Fisher SJ (2014) Preterm labor: one syndrome, many causes. Science 345(6198):760–765

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Haram K, Mortensen JH, Morrison JC (2015) Tocolysis for acute preterm labor: does anything work. J Matern Fetal Neonatal Med 28(4):371–378

    Article  PubMed  Google Scholar 

  17. Haas DM et al (2012) Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ 345:e6226

    Article  PubMed  PubMed Central  Google Scholar 

  18. RCOG (2011) Tocolysis for Women in Preterm Labour. Green-top Guideline, 2011. 1b. RCOG, London

    Google Scholar 

  19. Eke AC et al (2016) A systematic review and meta-analysis of progestogen use for maintenance tocolysis after preterm labor in women with intact membranes. Int J Gynaecol Obstet 132(1):11–16

    Article  CAS  PubMed  Google Scholar 

  20. van Vliet E et al (2015) Maintenance tocolysis with nifedipine in threatened preterm labour: 2‑year follow up of the offspring in the APOSTEL II trial. BJOG. doi:10.1111/1471-0528.13586

    PubMed  Google Scholar 

  21. RCOG (2010) Antenatal Corticosteroids to Reduce Neonatal Morbidity and Mortality. Green-top Guideline No. 7, 2010. RCOG, London

    Google Scholar 

  22. Ecker JL et al (2015) 3: Periviable birth. Am J Obstet Gynecol 213(5):604–614

    Article  PubMed  Google Scholar 

  23. Gaspar R, Hajagos-Toth J (2013) Calcium channel blockers as tocolytics: principles of their actions, adverse effects and therapeutic combinations. Pharmaceuticals (Basel) 6(6):689–699

    Article  CAS  Google Scholar 

  24. Wray S et al (2003) Calcium signaling and uterine contractility. J Soc Gynecol Investig 10(5):252–264

    Article  CAS  PubMed  Google Scholar 

  25. Lima MM et al (2009) Doppler velocimetry of the uterine, umbilical and fetal middle cerebral arteries in pregnant women undergoing tocolysis with oral nifedipine. Ultrasound Obstet Gynecol 34(3):311–315

    Article  PubMed  Google Scholar 

  26. Grzesiak M, Ahmed RB, Wilczynski J (2013) 48-hours administration of nifedipine in spontaneous preterm labor – Doppler blood flow assessment of placental and fetal circulation. Neuro Endocrinol Lett 34(7):687–692

    CAS  PubMed  Google Scholar 

  27. Guclu S et al (2006) Nifedipine therapy for preterm labor: effects on placental, fetal cerebral and atrioventricular Doppler parameters in the first 48 hours. Ultrasound Obstet Gynecol 27(4):403–408

    Article  CAS  PubMed  Google Scholar 

  28. Flenady V et al (2014) Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database Syst Rev 6:Cd002255

    PubMed  Google Scholar 

  29. van Vliet EO et al (2014) Nifedipine versus atosiban in the treatment of threatened preterm labour (assessment of Perinatal outcome after specific Tocolysis in early labour: aPOSTEL III-trial). BMC Pregnancy Childbirth 14:93

    Article  PubMed  PubMed Central  Google Scholar 

  30. Naik Gaunekar N et al (2013) Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev 10:Cd004071

    PubMed  Google Scholar 

  31. Parry E et al (2014) The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour. Aust N Z J Obstet Gynaecol 54(3):231–236

    Article  PubMed  Google Scholar 

  32. World Health Organization (2015) WHO guidelines approved by the guidelines review committee. In: WHO recommendations on interventions to improve preterm birth outcomes. World Health Organization, Geneva

    Google Scholar 

  33. Eliasson R, Posse N (1960) The effect of prostaglandin on the nonpregnant human uterus in vivo. Acta Obstet Gynecol Scand 39(1):112–126

    Article  CAS  PubMed  Google Scholar 

  34. Zuckerman H, Reiss U, Rubinstein I (1974) Inhibition of human premature labor by indomethacin. Obstet Gynecol 44(6):787–792

    CAS  PubMed  Google Scholar 

  35. Goldenberg RL et al (2008) Epidemiology and causes of preterm birth. Lancet 371(9606):75–84

    Article  PubMed  Google Scholar 

  36. Rinaldi SF et al (2011) Anti-inflammatory mediators as physiological and pharmacological regulators of parturition. Expert Rev Clin Immunol 7(5):675–696

    Article  CAS  PubMed  Google Scholar 

  37. Romero R et al (2006) The preterm parturition syndrome. BJOG 113(3):17–42

    Article  CAS  PubMed  Google Scholar 

  38. Abou-Ghannam G, Usta IM, Nassar AH (2012) Indomethacin in pregnancy: applications and safety. Am J Perinatol 29(3):175–186

    Article  PubMed  Google Scholar 

  39. Hammers AL, Sanchez-Ramos L, Kaunitz AM (2015) Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis. Am J Obstet Gynecol 212(4):1–13

    Article  Google Scholar 

  40. Loe SM, Sanchez-Ramos L, Kaunitz AM (2005) Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet Gynecol 106(1):173–179

    Article  PubMed  Google Scholar 

  41. Reinebrant HE et al (2015) Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 6:Cd001992

    PubMed  Google Scholar 

  42. Lopez Bernal A (2007) The regulation of uterine relaxation. Semin Cell Dev Biol 18(3):340–347

    Article  CAS  PubMed  Google Scholar 

  43. Neilson JP, West HM, Dowswell T (2014) Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2:Cd004352

    PubMed  Google Scholar 

  44. Flenady V et al (2014) Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev 6:Cd004452

    PubMed  Google Scholar 

  45. Wex J et al (2011) Atosiban versus betamimetics in the treatment of preterm labour in Italy: clinical and economic importance of side-effects. Eur J Obstet Gynecol Reprod Biol 157(2):128–135

    Article  CAS  PubMed  Google Scholar 

  46. Wex J, Connolly M, Rath W (2009) Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation. BMC Pregnancy Childbirth 9:23

    Article  PubMed  PubMed Central  Google Scholar 

  47. Siassakos D, O’Brien K, Draycott T (2009) Healthcare evaluation of the use of atosiban and fibronectin for the management of pre-term labour. J Obstet Gynaecol (Lahore) 29(6):507–511

    Article  CAS  Google Scholar 

  48. Crowther CA et al (2014) Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 8:Cd001060

    PubMed  Google Scholar 

  49. Haas DM et al (2015) Ethanol for preventing preterm birth in threatened preterm labor. Cochrane Database Syst Rev 11:Cd011445

    PubMed  Google Scholar 

  50. Flenady V et al (2013) Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev 12:Cd000246

    PubMed  Google Scholar 

  51. Stan CM et al (2013) Hydration for treatment of preterm labour. Cochrane Database Syst Rev 11:Cd003096

    PubMed  Google Scholar 

  52. Sosa CG et al (2015) Bed rest in singleton pregnancies for preventing preterm birth. Cochrane Database Syst Rev 3:Cd003581

    PubMed  Google Scholar 

  53. Plangger N et al (2006) Intravenous tocolysis with Bryophyllum pinnatum is better tolerated than beta-agonist application. Eur J Obstet Gynecol Reprod Biol 124(2):168–172

    Article  CAS  PubMed  Google Scholar 

  54. Khianman B et al (2012) Relaxation therapy for preventing and treating preterm labour. Cochrane Database Syst Rev 8:Cd007426

    PubMed  Google Scholar 

  55. Vogel JP et al (2014) Combination of tocolytic agents for inhibiting preterm labour. Cochrane Database Syst Rev 7:Cd006169

    PubMed  Google Scholar 

  56. Martinez de Tejada B et al (2015) Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial. BJOG 122(1):80–91

    Article  CAS  PubMed  Google Scholar 

  57. Suhag A, Saccone G, Berghella V (2015) Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials. Am J Obstet Gynecol 213(4):479–487

    Article  CAS  PubMed  Google Scholar 

  58. Eke AC et al (2016) A systematic review and meta-analysis of progestogen use for maintenance tocolysis after preterm labor in women with intact membranes. Int J Gynaecol Obstet 132(1):11–16

    Article  CAS  PubMed  Google Scholar 

  59. Pařízek A, Koucký M, Dušková M (2014) Progesterone, inflammation and preterm labor. J Steroid Biochem Mol Biol 139:159–165

    Article  PubMed  Google Scholar 

  60. Baumbach J et al (2012) Inhibition of uterine contractility with various tocolytics with and without progesterone: in vitro studies. Am J Obstet Gynecol 206(3):1–5

    Article  Google Scholar 

  61. Pearl J et al (2011) Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy. Surg Endosc 25(11):3479–3492

    Article  PubMed  Google Scholar 

  62. Smith J, DeFranco EA (2015) Tocolytics used as adjunctive therapy at the time of cerclage placement: a systematic review. J Perinatol 35(8):561–565

    Article  CAS  PubMed  Google Scholar 

  63. Cluver C et al (2015) Interventions for helping to turn term breech babies to head first presentation when using external cephalic version. Cochrane Database Syst Rev 2:Cd000184

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. Voigt.

Ethics declarations

Interessenkonflikt

F. Voigt, A. Farrokh, C. Franz, N. Maass, E. Stickeler und T.W. Goecke geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Additional information

Redaktion

W. Janni, Ulm

R. Kimmig, Essen

N. Maass, Kiel

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Voigt, F., Farrokh, A., Franz, C. et al. Tokolyse – Update 2016. Gynäkologe 49, 201–211 (2016). https://doi.org/10.1007/s00129-016-3844-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-016-3844-y

Navigation